ISN Webinar: New Perspectives in the Management of CKD in T2D – the Emerging Role of MRAs
Despite the recent advances in the management CKD in T2D, there are residual risks that need to be tackled by new therapies.
This webinar will review the role of MRAs, including data from recent clinical trials, on the treatment of the progression of CKD in T2D.
Learning objectives:
- Describe the current understanding of the mechanisms involved in the progression of DKD.
- Improve understanding of the role of MRAs in the treatment of DKD.
- Review data from clinical trials with established and new MRA therapies.
- Date: December 16, 2020
- Time: 6 p.m. CET
This webinar is supported by an unrestricted educational grant from Bayer 
